Skip to main content
. 2022 Jul;23(7):2375–2378. doi: 10.31557/APJCP.2022.23.7.2375

Table 1.

Patients’ Characteristics

Total patients, n 70
Interval time between ischemic stroke and cancer, median (range), months 53.0 (0.1-363.0)
Male, n (%) 45 (64.3)
Age, mean (range), years 76.5 (39-91)
Surgery for cancer, n (%) 53 (75.7)
Chemotherapy for cancer, n (%) 23 (32.9)
Hypertension, n (%) 49 (70.0)
Diabetes, n (%) 32 (45.7%)
Smoking, n (%) 18 (25.7%)
Atrial fibrillation, n (%) 9 (12.9)
Dyslipidemia, n (%) 20 (28.6%)
Homocysteine, median (range), μmol/L 12.57 (2.16-54.69)
hs-CRP, median (range), mg/L 4.1 (0.3-165.9)
Fibrinogen, median (range), g/L 3.21 (1.28-6.90)
D-dimer, median (range), ng/ml 193 (36-5000)

hs-CRP, high-sensitivity C-reactive protein